ARTICLE | Company News
Guilford, Link Pharmaceuticals Ltd. sales and marketing update
May 24, 2004 7:00 AM UTC
GLFD granted Link exclusive marketing and distribution rights to its Gliadel wafer carmustine implant brain cancer drug in Germany, France, Benelux, Austria and Switzerland. GLFD received a $500,000 ...